These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30515743)
21. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques. Aljaroudi WA; Desai MY; Tang WH; Phelan D; Cerqueira MD; Jaber WA J Nucl Cardiol; 2014 Apr; 21(2):271-83. PubMed ID: 24347127 [TBL] [Abstract][Full Text] [Related]
27. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review. Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis. Brownrigg J; Lorenzini M; Lumley M; Elliott P ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121 [TBL] [Abstract][Full Text] [Related]
29. Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac Amyloidosis. Lee SP; Suh HY; Park S; Oh S; Kwak SG; Kim HM; Koh Y; Park JB; Kim HK; Cho HJ; Kim YJ; Kim I; Yoon SS; Seo JW; Paeng JC; Sohn DW J Am Coll Cardiol; 2020 Feb; 75(4):380-390. PubMed ID: 32000949 [TBL] [Abstract][Full Text] [Related]
30. Heart of the Matter: Decoding the Underdiagnosed Cardiac Amyloidosis. Kaiser ME; Lewis TJ Cureus; 2023 Dec; 15(12):e50527. PubMed ID: 38098740 [TBL] [Abstract][Full Text] [Related]
31. The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art. Popescu C; Burger IA Curr Radiopharm; 2021; 14(3):228-241. PubMed ID: 32525789 [TBL] [Abstract][Full Text] [Related]
35. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087 [TBL] [Abstract][Full Text] [Related]
36. Radiolabeled Thioflavin-T Derivative PET Imaging for the Assessment of Cardiac Amyloidosis. Boczar KE; Small G; Tavoosi A; Ruddy TD Curr Cardiol Rep; 2022 Dec; 24(12):1883-1891. PubMed ID: 36378483 [TBL] [Abstract][Full Text] [Related]
37. Cardiac manifestations of amyloid disease. Rivera RJ; Vicenty S Bol Asoc Med P R; 2008; 100(4):60-70. PubMed ID: 19400531 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic Performance of Abnormal Nulling on Cardiac Magnetic Resonance Imaging Look Locker Inversion Time Sequence in Differentiating Cardiac Amyloidosis Types. Tavoosi A; Yu B; Aghel N; Karur GR; Pakkal M; Wald R; Wintersperger BJ; Delgado DH; Hanneman K J Thorac Imaging; 2020 Sep; 35(5):334-339. PubMed ID: 32195888 [TBL] [Abstract][Full Text] [Related]
39. How to Image Cardiac Amyloidosis: A Practical Approach. Dorbala S; Cuddy S; Falk RH JACC Cardiovasc Imaging; 2020 Jun; 13(6):1368-1383. PubMed ID: 31607664 [TBL] [Abstract][Full Text] [Related]